Gabelli Funds LLC Purchases 94,600 Shares of Lionsgate Studios Corp. $LION

Gabelli Funds LLC raised its position in Lionsgate Studios Corp. (NYSE:LION - Free Report) by 14.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 728,000 shares of the company's stock after acquiring an additional 94,600 shares during the quarter. Gabelli Funds LLC owned approximately 0.25% of Lionsgate Studios worth $6,982,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of LION. GAMMA Investing LLC grew its stake in shares of Lionsgate Studios by 99.3% in the fourth quarter. GAMMA Investing LLC now owns 3,559 shares of the company's stock worth $32,000 after purchasing an additional 1,773 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Lionsgate Studios during the 4th quarter valued at about $44,000. Osaic Holdings Inc. raised its position in Lionsgate Studios by 4,852.0% during the 2nd quarter. Osaic Holdings Inc. now owns 4,952 shares of the company's stock valued at $29,000 after purchasing an additional 4,852 shares during the last quarter. CIBC Private Wealth Group LLC bought a new position in Lionsgate Studios during the 3rd quarter valued at approximately $38,000. Finally, Farther Finance Advisors LLC lifted its holdings in Lionsgate Studios by 4,457.3% in the 4th quarter. Farther Finance Advisors LLC now owns 5,970 shares of the company's stock worth $55,000 after buying an additional 5,839 shares during the period.

Lionsgate Studios Stock Performance

Shares of NYSE:LION opened at $13.25 on Tuesday. The firm has a market capitalization of $3.85 billion, a P/E ratio of -18.40 and a beta of 0.64. The stock has a 50 day moving average price of $14.19 and a 200-day moving average price of $11.49. Lionsgate Studios Corp. has a 52-week low of $5.65 and a 52-week high of $16.70.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Wall Street Zen lowered Lionsgate Studios from a "buy" rating to a "hold" rating in a research report on Saturday, June 13th. Robert W. Baird raised their price target on Lionsgate Studios from $18.00 to $20.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 17th. Barrington Research raised their price target on Lionsgate Studios from $14.50 to $17.00 and gave the stock an "outperform" rating in a research note on Tuesday, May 26th. Raymond James Financial reiterated an "outperform" rating and issued a $15.00 price target on shares of Lionsgate Studios in a report on Friday, May 22nd. Finally, Morgan Stanley boosted their price objective on shares of Lionsgate Studios from $11.00 to $14.00 and gave the company an "overweight" rating in a research report on Friday, May 1st. Six investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Lionsgate Studios has a consensus rating of "Hold" and an average price target of $15.57.

About Lionsgate Studios

Lionsgate Studios, operating under the ticker NYSE:LION, is a leading global entertainment company specializing in the production, acquisition and distribution of motion pictures, television programming and digital content. Headquartered in Santa Monica, California, and with additional operations in Vancouver, the company develops, finances and markets feature films that span a wide range of genres—from major franchise hits like The Hunger Games and John Wick to independent and specialty titles.

Want to see what other hedge funds are holding LION? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lionsgate Studios Corp. (NYSE:LION - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.